BLOG

Patent analysis and insight

Analysis and insight to bring more predictability, transparency, and equity to your patent prosecution.

Posts about

Business Development (4)

How to Use Prosecution Data to Quantify ROI to Clients

As businesses feel the lingering stress from the COVID-19 pandemic, some are considering bringing patent prosecution in-house in order to cut costs. With clients continuing to mind their budgets, how can firms demonstrate the cost savings and ROI they bring to the table?

Read More

The Future of Pharma: The AbbVie / Allergan Merger

Biopharmaceutical companies AbbVie Inc. and Allergan recently announced that they signed a consent decree with the U.S. Federal Trade Commission that will commit the companies to sell some properties if they commence a planned merger.

Read More

Why Companies Want Their Outside Counsel to Use Data Analytics

Big business is all about data. We see it in almost every industry, from healthcare to financial services to aviation and beyond. But the legal industry has been slow to adapt.

Read More

The Future of Television: The T-Mobile / Comcast Merger

Executives at T-Mobile may be weighing a potential merger with Comcast, the largest U.S. cable provider. 

Read More

Patents for Humanity: Invention for Social Good

Patents for Humanity is the USPTO awards competition recognizing inventors and innovators who develop game-changing technology to meet global humanitarian challenges. With the application deadline quickly approaching, we take a look at some of the past award recipients and celebrate their impact on society today.

Read More

Future of Transportation: The Fiat Chrysler / Peugeot Merger

Fiat Chrysler and Peugeot owner PSA Group recently announced the terms of a $48 billion merger that would create the world's fourth-largest automaker. A primary reason for the merger is to share the cost of developing electric and autonomous vehicles.

Read More

Beyond Allowance Rate: How to Highlight Firm Success at the USPTO

We often use allowance rate as a quick and simple way to quantify success at the USPTO -- and we know law firms use it too. However, that is just one of many indicators in-house counsel can use to evaluate firm performance. 

Read More
Pfizer Mylan Header

Future of Pharma: The Pfizer / Mylan Merger

Pfizer and Mylan, the maker of EpiPens, are merging. Pfizer will offload Upjohn, its portfolio of drugs that are no longer protected by patents, including Viagra, Lipitor and Celebrex, combining with rival Mylan to create a new company that will have a new, yet-to-be-announced name.

Read More
UT _ Raytheon

Future of Defense: The United Technologies / Raytheon Merger

United Technologies, an American multinational conglomerate, recently agreed to combine its aerospace business with military contractor Raytheon, creating a new manufacturing giant in the aerospace and defense sectors. Under the new name of Raytheon Technologies, the merged company would have about $74 billion in expected sales for 2019. 

Read More
cover photo

Three Steps for a Winning, Data-Backed Client Pitch

When looking for outside counsel, companies are likely hearing similar pitches from all law firms. Business intelligence can be a powerful differentiator, a tool that helps law firms identify areas of strength and discover new pathways to success. It can lead to more focused marketing efforts and a general uptick in client buy-in.

Read More

Are you ready to transform your patent practice?

Patent prosecution is complex – we know. If you’re ready for simpler workflows and more predictable outcomes, give us a call.